Allyson Berent
Company: Chief Operating Officer, GeneTx Biotherapeutics
Job title: Chief Scientific Officer, FAST
Seminars:
Live Q&A Session with Your Expert Speakers 7:20 pm
day: Day One
Angelman Syndrome Biomarker & Outcome Measure Consortium (ABOM): Understanding What Matters to Patients with a Heterogenous Neurodevelopmental Disorder 6:20 pm
• NHS, Disease concept models and focus domains on what is important to patients and caregivers: Staying pre-competitiveRead more
day: Day One
A Journey Through Drug Development for Angelman Syndrome 8:40 am
• Bringing together Passion, Community, Great Science and a Vision is key to success • Support many different therapeutic platforms has value • Supporting NHS and endpoint consortia has served the AS community well in industryRead more
day: Day One